🇺🇸 FDA
Patent

US 6924118

Recombinant intracellular pathogen immunogenic compositions and methods for use

expired A61KA61K2039/522A61K2039/523

Quick answer

US patent 6924118 (Recombinant intracellular pathogen immunogenic compositions and methods for use) held by The Regents of the University of California expires Mon Jul 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 02 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
34
CPC classes
A61K, A61K2039/522, A61K2039/523, A61K38/00, A61K39/04